Updating the OMERACT filter : discrimination and feasibility
The "Discrimination" part of the OMERACT Filter asks whether a measure discriminates between situations that are of interest. "Feasibility" in the OMERACT Filter encompasses the practical considerations of using an instrument, including its ease of use, time to complete, monetary costs, and interpretability of the question(s) included in the instrument. Both the Discrimination and Reliability parts of the filter have been helpful but were agreed on primarily by consensus of OMERACT participants rather than through explicit evidence-based guidelines. In Filter 2.0 we wanted to improve this definition and provide specific guidance and advice to participants.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
The Journal of rheumatology - 41(2014), 5 vom: 01. Mai, Seite 1005-10 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wells, George [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Consensus Development Conference |
|---|
| Anmerkungen: |
Date Completed 04.02.2015 Date Revised 31.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3899/jrheum.131311 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM236984330 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM236984330 | ||
| 003 | DE-627 | ||
| 005 | 20231224110715.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3899/jrheum.131311 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0790.xml |
| 035 | |a (DE-627)NLM236984330 | ||
| 035 | |a (NLM)24692522 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wells, George |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Updating the OMERACT filter |b discrimination and feasibility |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.02.2015 | ||
| 500 | |a Date Revised 31.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The "Discrimination" part of the OMERACT Filter asks whether a measure discriminates between situations that are of interest. "Feasibility" in the OMERACT Filter encompasses the practical considerations of using an instrument, including its ease of use, time to complete, monetary costs, and interpretability of the question(s) included in the instrument. Both the Discrimination and Reliability parts of the filter have been helpful but were agreed on primarily by consensus of OMERACT participants rather than through explicit evidence-based guidelines. In Filter 2.0 we wanted to improve this definition and provide specific guidance and advice to participants | ||
| 650 | 4 | |a Consensus Development Conference | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a DISCRIMINATION | |
| 650 | 4 | |a FEASIBILITY | |
| 650 | 4 | |a OUTCOME AND PROCESS ASSESSMENT | |
| 650 | 4 | |a OUTCOME MEASURES IN RHEUMATOLOGY | |
| 700 | 1 | |a Beaton, Dorcas E |e verfasserin |4 aut | |
| 700 | 1 | |a Tugwell, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Boers, Maarten |e verfasserin |4 aut | |
| 700 | 1 | |a Kirwan, John R |e verfasserin |4 aut | |
| 700 | 1 | |a Bingham, Clifton O |c 3rd |e verfasserin |4 aut | |
| 700 | 1 | |a Boonen, Annelies |e verfasserin |4 aut | |
| 700 | 1 | |a Brooks, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Conaghan, Philip G |e verfasserin |4 aut | |
| 700 | 1 | |a D'Agostino, Maria-Antonietta |e verfasserin |4 aut | |
| 700 | 1 | |a Dougados, Maxime |e verfasserin |4 aut | |
| 700 | 1 | |a Furst, Daniel E |e verfasserin |4 aut | |
| 700 | 1 | |a Gossec, Laure |e verfasserin |4 aut | |
| 700 | 1 | |a Guillemin, Francis |e verfasserin |4 aut | |
| 700 | 1 | |a Helliwell, Philip |e verfasserin |4 aut | |
| 700 | 1 | |a Hewlett, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Kvien, Tore K |e verfasserin |4 aut | |
| 700 | 1 | |a Landewé, Robert B |e verfasserin |4 aut | |
| 700 | 1 | |a March, Lyn |e verfasserin |4 aut | |
| 700 | 1 | |a Mease, Philip J |e verfasserin |4 aut | |
| 700 | 1 | |a Ostergaard, Mikkel |e verfasserin |4 aut | |
| 700 | 1 | |a Simon, Lee |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Jasvinder A |e verfasserin |4 aut | |
| 700 | 1 | |a Strand, Vibeke |e verfasserin |4 aut | |
| 700 | 1 | |a van der Heijde, Désirée M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of rheumatology |d 1983 |g 41(2014), 5 vom: 01. Mai, Seite 1005-10 |w (DE-627)NLM000019593 |x 1499-2752 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2014 |g number:5 |g day:01 |g month:05 |g pages:1005-10 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3899/jrheum.131311 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2014 |e 5 |b 01 |c 05 |h 1005-10 | ||